Dr. Shikhar Agarwal, MD, MPH

Dr. Agarwal practices at Geisinger Medical Center in Danville, Pennsylvania, part of Risant Health.

Dr. Agarwal's NPI, 1326212101, was assigned on April 14, 2008. Dr. Agarwal graduated from All India Institute of Medical Sciences in 2006. Dr. Agarwal holds Pennsylvania license MD458166.

Dr. Agarwal's primary practice is Geisinger Medical Center, at 100 North Academy Avenue, Danville, PA 17822 in Montour County. The practice phone is (570) 271-6211.

Dr. Agarwal's primary practice is Geisinger Medical Center in Danville, Pennsylvania, part of Risant Health. Dr. Agarwal is also affiliated with Geisinger Lewistown Hospital. The medical group on file is Geisinger. Dmand AI also links Dr. Agarwal to 3 more hospitals and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Agarwal practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Agarwal's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Agarwal is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Agarwal's licenses on file in 2 states: Pennsylvania and Ohio.

Dmand AI lists angioplasty, cardiac catheterization and circulation problems among the conditions Dr. Agarwal treats.

CMS data shows 1,354 Medicare services from Dr. Agarwal across 13 procedure codes in 2024, for 1,018 Medicare patients. Medicare paid $83,075 for them.

CMS counts 1,018 Medicare patients who saw Dr. Agarwal in 2024. The largest group is 65 to 74, with 390 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Agarwal's median patient age at 76, with 47% women.

In 2024, Dr. Agarwal wrote 207 Medicare Part D claims for 56 patients. 82% of them were for generic drugs. CMS names the drug for 131 of them, across 7 drugs with 11 or more claims each, at $23,905 in total drug cost. In 2023, CMS named 124 claims across 8 drugs.

Dr. Agarwal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 24 procedures of coronary angioplasty and stenting by Dr. Agarwal, more than 57% of the clinicians it reports for that procedure.

Dmand AI links 147 papers to Dr. Agarwal, published from 2008 to 2024. 2015 was the busiest year, with 24. The most frequent topics are Percutaneous Coronary Intervention, Cardiac Catheterization and Stroke. Dr. Agarwal has published most often in JACC Cardiovasc Interv. Dr. Agarwal's most frequent co-authors are Akhil Parashar, MD, Brian P. Griffin, MD and Navkaranbir S. Bajaj, MD.

Dmand AI links Dr. Agarwal to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Foramen Ovale, Patent and Heart Septal Defects, Atrial.

CMS Open Payments shows 198 general payments to Dr. Agarwal from 15 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 39% of the total. Edwards Lifesciences Corporation paid the most, $26,253.

Dr. Agarwal graduated from All India Institute of Medical Sciences in 2006.

Dr. Agarwal is in network with 12 carriers, including Aetna, Elevance and Highmark. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.